Orion Infusion Limited (DSE:ORIONINFU)

Market Cap	11.20B
Revenue (ttm)	675.08M
Net Income (ttm)	41.22M
Shares Out	20.36M
EPS (ttm)	2.02
PE Ratio	271.73
Forward PE	n/a
Dividend	1.20 (0.21%)
Ex-Dividend Date	Dec 5, 2024

Volume	419,294
Average Volume	486,414
Open	547.80
Previous Close	535.00
Day's Range	547.80 - 565.00
52-Week Range	217.20 - 565.00
Beta	-2.43
RSI	78.11
Earnings Date	Nov 4, 2025

About Orion Infusion

Orion Infusion Limited manufactures and sells large volume parenteral and other lifesaving injectable products in Bangladesh. The company offers I.V. rehydration, electrolyte, and acidosis solutions; ranitidine I.V. infusion; anti-microbial products; metronidazole I.V; pure steam generated fluids; and amino acids solution. The company was formerly known as Mala Chemical & Pharmaceuticals Industries Ltd. and changed its name to Orion Infusion Limited in 1994. Orion Infusion Limited was incorporated in 1983 and is based in Dhaka, Bangladesh.

• Industry: Biological Products, Except Diagnostic Substances
• Founded: 1983
• Employees: 718
• Stock Exchange: Dhaka Stock Exchange
• Ticker Symbol: ORIONINFU

Financial Performance

In 2024, Orion Infusion's revenue was 827.42 million, an increase of 2.13% compared to the previous year's 810.15 million. Earnings were 42.33 million, an increase of 1.03%.